NCT07119125View on ClinicalTrials.gov

A First-in-human, 3-part Study of MRT-8102 in Healthy Participants and Participants at Cardiovascular Risk With Elevated CRP

PHASE1RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

June 27, 2025

Primary Completion Date

January 31, 2026

Study Completion Date

March 31, 2026

Conditions
Healthy VolunteersElevated CRP
Interventions
DRUG

MRT-8102

Oral capsules

DRUG

Placebo

Oral capsules

Trial Locations (4)

33172

RECRUITING

Clinical Pharmacology of Miami, LLC, Miami

65807

RECRUITING

QPS, Springfield

66219

RECRUITING

ICON Clinical Research, Lenexa

78240

RECRUITING

Endeavor Clinical Trials, San Antonio

Sponsors
All Listed Sponsors
lead

Monte Rosa Therapeutics, Inc

INDUSTRY

NCT07119125 - A First-in-human, 3-part Study of MRT-8102 in Healthy Participants and Participants at Cardiovascular Risk With Elevated CRP | Biotech Hunter | Biotech Hunter